• Thu, December 7, 2023
Caitlin Cronin Reiterated (AXGN) at Strong Buy with Decreased Target to $11 on, Dec 7th, 2023
Caitlin Cronin of Canaccord Genuity, Reiterated "AxoGen, Inc." (AXGN) at Strong Buy with Decreased Target from $15 to $11 on, Dec 7th, 2023.
Caitlin has made no other calls on AXGN in the last 4 months.
There are 3 other peers that have a rating on AXGN. Out of the 3 peers that are also analyzing AXGN, 0 agree with Caitlin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Caitlin
- Mike Kratky of "Leerink Partners" Initiated at Buy and Held Target at $9 on, Monday, October 16th, 2023
- Ross Osborn of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $16 on, Tuesday, September 26th, 2023
- Travis Steed of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $16 on, Tuesday, August 22nd, 2023
Like: 👍
